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UL84-independent replicationThe UL84 gene of human cytomegalovirus is implicated in the initiation of viral DNA replication during lytic
infection. UL84 is essential for replication of a cloned viral origin of lytic replication (oriLyt) in vitro and
mutants of strains AD169 or Towne with deletions or insertions in UL84 fail to grow in cells permissive for
wild type virus. Here we show that UL84 is dispensable for replication of a strain TB40/E clone derived from
a bacterial artiﬁcial chromosome. The genomes of the ﬁbroblast-adapted strains AD169 and Towne are
altered substantially from the consensus for strains that have not been propagated extensively in cell culture.
The parental TB40/E genome conforms to the consensus genomic organization. Accordingly, natural HCMV
strains may possess replication capability that extends beyond the known oriLyt-dependent replication
system of laboratory strains.and Immunology H107, Penn
ive, Hershey, PA 17033, USA.
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Replication of herpes virus DNA requires gene activities that direct
speciﬁc initiation at viral origins by conserved replication fork
proteins. For human cytomegalovirus (HCMV) a product of the UL84
gene is required for replication of a plasmid containing a cloned lytic
origin of replication, oriLyt (Anders and Punturieri, 1991; Hamzeh et
al., 1990), in a transient transfection assay (Pari and Anders, 1993;
Sarisky and Hayward, 1996), and UL84 protein is associated with
oriLyt in infected cells (Colletti et al., 2007). Unlike the origin binding
protein pUL9 of herpes simplex virus, which is required for origin
function of that virus (Elias et al., 1986; Olivo et al., 1988), there is no
evidence that UL84 encodes a sequence-speciﬁc DNA binding protein.
Rather, UL84 participates in a mechanism that bypasses the
requirement for a UL9 ortholog in HCMV (Sarisky and Hayward,
1996). UL84 is likely to be recruited to oriLyt through association with
one or more viral transcription factors encoded by the IE2 gene
(Sanders et al., 2008; Spector and Tevethia, 1994; Xu et al., 2004a)
and/or the polymerase subunit product of the UL44 gene (Strang et
al., 2009).
Evidence that the role of UL84 in viral DNA replication is essential
for viability comes from genetic analysis of the virus, which is
facilitated by the manipulation of viral genomes cloned in bacterial
artiﬁcial chromosomes (Borst et al., 1999; Marchini et al., 2001; Yuet al., 2002). Wild type clones are considered to be infectious if they
produce virus after introduction into cells in culture that are
permissive for non-BAC derived virus. Failure of a BAC clone with a
mutated gene to produce virus after introduction into cells is taken as
evidence that the gene is essential for growth in these conditions
(Dunn et al., 2003; Yu et al., 2003). By this criterion, UL84 is essential
for growth of strains AD169 (Xu et al., 2004b; Yu et al., 2003) and
Towne (Dunn et al., 2003). At least one of the AD169 mutants,
UL84ins-BAC, fails to replicate viral DNA and replication compartment
structures do not form even though all classes of viral RNA
accumulate, including those normally synthesized after the onset of
DNA replication (Xu et al., 2004b).
pUL84 has nuclear import and export signals and can shuttle
between the nucleus and the cytoplasm (Lischka et al., 2006, 2003; Xu
et al., 2002). Additionally, there is evidence that pUL84 self-associates
and is phosphorylated (Coletti et al., 2004, 2006). A number of other
activities are associated with UL84 including the interaction between
UL84 and IE2 gene products resulting in modulating transcriptional
activation and repression by IE2 (Gebert et al., 1997). Using proteomic
approaches incorporating mass spectrometry, interactions between
UL84 proteins and other viral and cellular proteins have been
proposed (Gao et al., 2008). The authenticity of some of these
interactions is supported by further analysis of infected and
transfected cells (Gao et al., 2008). Among these, the interaction
with casein kinase 2 is implicated in UL84's replication function. UL84
is related to an ancestral dUTPase, but the gene products are predicted
to be enzymatically inactive (Davison and Stow, 2005). There is a
disputed (Davison and Stow, 2005) claim that the protein belongs to
DExD/H box family of helicases and exhibits UTPase (unrelated
functionally to dUTPase) activity (Coletti et al., 2006).
Fig. 2. Foci of spreading viral infection detected by GFP ﬂuorescence. MRC5 cells were
infected in 6-well dishes at a MOI of 0.01, an agar overlay containing medium was
added, and cultures were visualized 9 days after infection. Images were captured with a
10× objective. Top: TB40GFP; bottom: TB40GFPΔ84GalK.
172 Rapid CommunicationThe strong circumstantial evidence linking UL84 origin function to
viral viability, along with the possibility that the gene might have
undiscovered roles in infection, led us to initiate a structure-function
analysis. The AD169 and Towne strains are ﬁbroblast-adapted and,
based on comparison to the consensus structure for cloned viral
genomes that have undergone more limited passage in culture, have
experienced substantial genomic alteration (Cha et al., 1996; Murphy
et al., 2003b; Sinzger et al., 1999) (Fig. 1). For the work here we chose
a clone of strain TB40/E whose genome arrangement conforms to the
consensus (Fig. 1, Sinzger et al., 2008, 1999). TB40-BAC4 grows
efﬁciently in endothelial, epithelial, and ﬁbroblast cell lines (Sinzger
et al., 2008, 1999). In course, we discovered that a TB40-BAC4 mutant
with a complete replacement of the UL84 gene by a bacterial genetic
marker unexpectedly retained viability.
Results
A TB40-BAC4 clone containing a gfp-expression cassette
(TB40GFPBAC) with a total gene replacement of UL84 was isolated
to evaluate potential complementation strategies for strains harbor-
ing lethal UL84 mutations. The new BAC, TB40GFPBACgalKΔ84,
contained a bacterial galactokinase expression cassette inserted in
place of UL84. UL84 encodes at least two proteins (He et al., 1992), the
larger of which is likely to be a 39-amino acid amino terminal
extension of the smaller. At least one of the proteins may be a minor
component of the virion (Varnum et al., 2004). Our mutant replaced
the reading frame for the smaller protein, the same reading frame
altered previously by others (Dunn et al., 2003; Yu et al., 2003). This
protein is synthesized a few hours after infection and, based on the
requirement for the previous synthesis of viral immediate early
proteins, has been assigned to the early class. The larger product
accumulates late in infection (He et al., 1992).
Since UL84mutations in AD169 and Towne are lethal, we expected
that TB40GFPBACgalKΔ84 would fail to produce virus. However,
when the BAC was electroporated into MRC5 cells, foci of spreading
green ﬂuorescent cells were observed. The foci spread at about the
same rate as those produced by the parent TB40GFPBAC. The relative
intensity of ﬂuorescence in cells infected with the UL84-deﬁcient
strain was somewhat reduced (Fig. 2). The TB40GFPBACgalKΔ84 virus
stocks produced subsequently had titers near those of TB40GFPBAC
(data not shown, but see Fig. 8 below). To conﬁrm that the mutant
virus stocks were derived from only the mutant BAC, viral DNA
extracted from the stocks was ampliﬁed with primer pairs speciﬁc for
the wild type or mutated UL84 region. The mutant produced the
expected product with the galK-speciﬁc primer, but no UL84 speciﬁc
product was detected after 30 ampliﬁcation cycles (Fig. 3). To ensure
that the BAC clones did not have another copy of the UL84 gene in
another location, BAC DNAwas digested with BamHI, separated by gel
electrophoresis, and blotted. The BamHI digestion patterns of the wildFig. 1. Genome organization of HCMV BAC clones [after (Murphy et al., 2003b)]. The
maps are standardized to position 1 in the ad169 sequence (Chee et al., 1990). Each
strain contains the RL gene block (1–14), which is repeated internally as an inversion
(IRL) in ad169 and Towne, whose other copy is designated as TRL. The TB40 clone UL
gene block (1–151) contains 18 genes that are not present in ad169. Towne is missing
UL132–146 and contains genes missing in ad169 (UL147–154), only some of which are
shared with TB40. The IRS-US-TRS regions of the clones differ in that the bacterial
artiﬁcial chromosome sequence in ad169, inserted next to US28, does not delete any
open reading frames, whereas the BACs in the other two clones delete the open reading
frames indicated in parentheses.type andmutant BACs were those predicted from the published TB40-
BAC4 sequence (Sinzger et al., 2008) after accounting for the galK
cassette replacement of the UL84 gene in the mutant (Fig. 4, stained
gel). When blots were probedwith UL84 or GalK sequences, the bands
obtained were those expected (Fig. 4, probed blots) and no other
signals were observed. We conclude that the original TB40BAC cloneFig. 3. Ampliﬁcation of DNA sequences in viral DNA and BAC clones. BAC or viral DNA
was prepared and ampliﬁed with primers speciﬁc for UL84 or GalK as described in
Materials and methods. The diagram shows the bands predicted from the position of
the primers. Lane designations: (1) TB40GFPΔ84GalK viral DNA; (2) TB40GFPΔ84GalK
BAC DNA; (3) TB40GFP BAC DNA; (4) No DNA; M. DNA markers.
Fig. 4. UL84 DNA sequences in BAC clones. BAC DNA was digested with BamHI and
separated by electrophoresis in 0.8% agarose gels. The center lane contained DNA size
markers. The two sets of lanes were blotted to nitrocellulose and probed with either the
UL84- or GalK-speciﬁc probes.
Fig. 5. Assay of UL84 expression in virus-infected cells by ﬂuorescent antibody. MRC5
cells were infectedwith TB40GFPBAC (TB40) or TB40GFPBACΔ84GalK (Δ84) at aMOI of
0.1–0.5 and ﬁxed at 24 h post infection. Cells were stained with mAb 9G3 (UL84) or 3A9
(IE2) and images were captured with a 20× objective. No stained cells were observed in
the samples infected with Δ84 and stained with 9G3. A representative ﬁeld is shown to
illustrate the background ﬂuorescence.
Fig. 6. Assay of protein expression in infected cells by immunoblotting. MRC5 cells were
infected with TB40GFPBAC (TB40) or TB40GFPBACΔ84GalK (Δ84) at a MOI of 0.5–1.0,
and extracts were prepared at 48 h post infection. Blots were probed with mAb 9G3
(UL84), 3A9 (IE2), 1D12 (IE1), or anti-tubulin. The series of IE2-speciﬁc bands are
probably the result of some combination of partial degradation products of the 86 kDa
protein and the multiple species of IE2 proteins that accumulate in late infected cells.
The migration positions of Precision Plus Protein Standards (Bio-Rad Corp) are shown
on the right.
173Rapid Communicationhad a single copy of UL84 and that this copy was completely lost in the
mutant.
A galKΔ84 derivative was isolated similarly from three other
starting BACs: TB40, TB40mCherry, and AD169. Bothmutated TB40/E-
derived strains were viable and the virus stocks had titers similar to
those of the GFP derivatives (data not shown). Thus, the replication
capability of the original Δ84 derivative of TB40GFPBAC was not the
result of an unusual occurrence, nor was the color marker expression
cassette somehow responsible for its viability. The mutated AD169
strain failed to produce virus (data not shown), as observed
previously (Yu et al., 2003). The TB40/E mutants also were viable in
HFF cells and HEL cells (data not shown), demonstrating that the
viability of the virus was not related to our use of MRC5 cells, which
had not been used previously to evaluate the growth of UL84mutants.
TB40GFPBAC and TB40GFPBACgalKΔ84 also grew in ARPE19 cells
with kinetics and yields similar to those obtained in MRC5 cells (data
not shown).
Expression of UL84 protein in virus-infected cells was evaluated by
two different assays. By immunoﬂuorescence UL84 was detected
primarily in the nuclei of TB40GFPBAC-infected cells, but none could
be detected above background in TB40GFPBACgalKΔ84-infected cells
at 24 (Fig. 5), 48, or 72 h (data not shown) after infection. Infection by
themutant was demonstrated by expression of IE2 proteins. Similarly,
by a protein immunoblotting assay, UL84 protein was detected in
TB40GFPBAC-infected cells at 48 h after infection but not in UL84
mutant-infected cells (Fig. 6). Based on the kinetics of viral DNA
accumulation in infected cells (see Fig. 7, below), this time point
corresponded to the late phase of infection in both strains. At this
time, one would expect UL84 to be detected easily if it were produced
(Samaniego et al., 1994). The mutant-infected cells expressed both
IE1 and IE2 proteins, possibly at levels greater than those obtained
with the UL84-intact strain.
Two experiments were performed to examine the replication
capacity of themutant strain. In the ﬁrst, MRC5 cells were infected at a
multiplicity of 0.5 and the accumulation of viral DNA was examined
over a 4-day time course. The kinetics of accumulation for both the
parent and mutant strains were similar, with a modest lag and about
half a log reduction in DNA accumulation in mutant-infected cells
(Fig. 7). To examine the replication capacity of the mutant straindirectly, MRC5 cells were infected at a multiplicity of 0.01 and virus
accumulation in the cells andmediumwas assayed over a 16-day time
course. As shown in Fig. 8, TB40GFPBACgalK84 exhibited growth
kinetics similar to that of the parental strain and the maximal yield of
mutant virus was again about half a log lower than that of the wild
type.
Discussion
Laboratory-cultivated strains of HCMV undergo many genetic
alterations including large deletions and duplications (Cha et al.,
1996). These changes have been linked to phenotypic differences such
as altered host range (Gerna et al., 2005; Hahn et al., 2004; Sinzger et
al., 1999; Wang and Shenk, 2005) and complicate the extrapolation of
the results of in vitro cell culture experiments to natural infections.
Our ﬁnding of an apparent difference in the replication systems of
HCMV strains adds a new dimension to this issue. The capacity of a
Fig. 7. Viral DNA accumulation in cells infected by a UL84-null strain of HCMV TB40/E.
Viral DNA accumulation was assayed in infected MRC5 cells and values corrected for
cell number as described inMaterials andmethods. The error bars indicate the standard
deviation of determinations from two independent cell samples (each determination
an average of triplicate assays). wt: TB40GFPBAC; Δ84: TB40GFPBACΔ84GalK.
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believed to be an “essential” replication gene makes it likely that at
least some natural strains possess replication capacity that extends
beyond the known oriLyt-dependent replication system of laboratory
strains. The alternative possibility, that somehow UL84-independent
replication was generated during culture and/or cloning of the TB40/
E isolate, seems remote but cannot be excluded completely.
The most obvious potential sources of enhanced replication
capacity in TB40/E include a more robust oriLyt, another origin of
replication that is UL84-independent, and/or a trans-acting function
that substitutes for that of UL84 at oriLyt. There are sequence
differences in oriLyt between TB40/E on one hand, and AD169 and
Towne on the other, including duplications and insertion/deletions
(Murphy et al., 2003b; Sinzger et al., 2008; D. Spector, unpublished
results). Notably, the differences between the AD169 and Towne
versions are more substantial than the differences between either and
TB40/E. Other non-coding regions of the strains exhibit sequence
variations, including duplications and insertion/deletions, that could
harbor another replication origin. Multiple origins of replication have
been discovered in alpha [e.g., herpes simplex virus type 1 (Frenkel et
al., 1976; Friedmann et al., 1977; Hirsch et al., 1977; Kaerner et al.,
1979, 1981; Locker and Frenkel, 1979; Mocarski and Roizman, 1981;
Spaete and Frenkel, 1982; Stow, 1982; Vlazny and Frenkel, 1981;
Weller et al., 1985)] and gamma [e.g., Epstein-Barr virus (Ham-
merschmidt and Sugden, 1988; Yates et al., 1984)] herpesviruses, so
beta herpesviruses such as HCMV might have multiple origins as
well.
With respect to trans-acting functions, there are several possible
sources of a replication activity that could be absent from AD169 and
Towne and expressed by TB40/E. A large block of open reading frames
in the UL segment is deleted in the ﬁbroblast-adapted strains (seeFig. 8. Replication of a UL84-null strain of HCMV TB40/E. Growth curves were
performed in infected MRC5 cells as described in Materials and methods. A
representative of three independent experiments is shown. wt: TB40GFPBAC; Δ84:
TB40GFPBACΔ84GalK.Fig. 1), although these genes do not encode any proteins predicted to
have a DNA replication-related activity. Some HCMV ORFs exhibit
considerable sequence divergence (Murphy et al., 2003b; Sinzger et
al., 2008), and for others there is uncertainty as to the coding potential
(Davison et al., 2003; Murphy et al., 2003a). Thus far, there is no
information on whether or not these ORFs can express an activity that
might substitute for UL84.
Whether at oriLyt or another site, one could imagine that the virus
has a UL84-independent replication system that participates in lytic or
persistent/latent infections in vivo, but is quickly lost upon in vitro
passage. If so, TB40-BAC4 could have retained this system. Clones of
the original TB40/E viral isolate are quite heterogeneous (Sinzger et
al., 2008) and the retention of a genetic region that is either
dispensable or selected against even after brief in vitro passage may
be idiosyncratic.
Gfp ﬂuorescence, DNA accumulation, and virus yield were reduced
modestly in mutant-infected cells. Expression levels of gfp, which is
detectable only after the onset of viral DNA replication, may reﬂect the
amount of late template. Accordingly, the UL84-independent replica-
tion system probably can compensate for most but not all of the UL84-
dependent replication capacity lost in the mutant-infected MRC5
cells. On the other hand, IE1 and IE2 protein accumulation appeared to
be elevated in mutant-infected cells. A quantitative analysis of viral
gene expression in these strains will be necessary to assess whether
the absence of UL84 has consequences for the accumulation of these
and other viral proteins.
The identiﬁcation of UL84 as an essential gene in the ﬁbroblast-
adapted strains raised the possibility that the gene might be a
therapeutic target (Kaiser et al., 2009). Continuation of such efforts
must take into account our ﬁnding that the gene may not be essential
for at least some outcomes of natural infections.Materials and methods
Cells and virus
MRC5 cells (ATCC CCL-171) were obtained from the American
Type Culture Collection. Human foreskin ﬁbroblasts (HFF; NHDF-Neo-
Der ﬁbroblasts, CC-2509) were purchase from Lonza. The origin of
human embryonic lung (HEL) cells was described previously
(Samaniego et al., 1994). Cells were maintained in Dulbecco's
modiﬁed Eagle's medium (DMEM, Invitrogen) supplemented with
2 mM glutamine, 100 U of penicillin per ml, 100 U of streptomycin per
ml, 0.15% sodium bicarbonate and 10% fetal bovine serum (Hyclone
Laboratories, Inc.). Human retinal pigmented epithelial cells (ARPE-
19, (Dunn et al., 1996)) were maintained in 50% DMEM/50% F12
(Invitrogen), supplemented as described above.
HCMV strains AD169, TB40-BAC4, TB40gfp, and TB40mCherry
were provided by Eain Murphy and Tom Shenk as bacterial artiﬁcial
chromosome (BAC) clones in Escherichia coli SW105 (Warming et al.,
2005). Expression of the color markers is mediated by an SV40 origin/
promoter in a cassette inserted between the US34 and TRS1 genes (E.
Murphy, personal communication).
BAC DNA was isolated from overnight bacterial cultures by a
modiﬁed cosmid isolation procedure. Brieﬂy, cells from 10 ml of
culture were suspended in 50 mM Tris, pH 8.0, 10 mM EDTA,
containing 200 μg/ml RNAse A. The solution was adjusted to 0.1 M
NaOH, 0.5% SDS to lyse the cells, placed on ice, and sodium acetate, pH
5.5, was added to a ﬁnal concentration of 1M. The solutionwas cleared
by centrifugation in a microcentrifuge for 15 min at 4 °C. The
supernatant was removed to a fresh tube and nucleic acid was
precipitated with an equal volume of 2-propanol. The nucleic acid was
collected by centrifugation, dissolved in 10 mM Tris, pH 8.0, 1 mM
EDTA, 150 mM NaCl, and precipitated with ethanol. The nucleic acid
was collected again, dried brieﬂy, and dissolved in 25 μl of 10 mMTris,
175Rapid CommunicationpH 7.4, 0.1 mM EDTA. Half of the suspension was used for
electroporation.
To produce virus, MRC5 cells just at conﬂuence were removed
from a 15-cm dish by trypsination, diluted with fresh medium,
collected by centrifugation, and suspended in 0.5 ml of growth
medium. The cell suspension was mixed with BAC DNA and 1 μg of
an expression vector for HCMV pp71 [pCGNpp71, (Murphy et al.,
2008)] and transferred to a 4-mm gap electroporation cell (Spectro-
cell). Electroporation was performed at a setting of 260 V/960 μF in
the Gene Pulsar X cell™ (Bio-Rad) with capacitance extender.
Electroporated cells were transferred in 10 ml of growth medium to
a 10-cm tissue culture dish and incubated at 37 °C until complete
cytopathic effect (CPE) was observed. The cells were scraped from the
surface of the dish into the medium and collected by centrifugation.
The supernatant was saved and 1 ml was added to the cell pellet. The
cells were suspended and then disrupted by soniﬁcation in a cup
sonicator (Misonix sonicator 3000). Cell debris was removed by
centrifugation and the supernatant was combined with the saved
supernatant and dispensed in aliquots for storage at −80 °C.
To prepare larger stocks, 1 ml of virus suspension prepared as
above was added to an 850 cm2 roller bottle of MRC5 cells in 50 ml of
medium. When complete CPE was observed, virus-containing lysates
were prepared by a procedure similar to that described above after
adjusting for the larger volume of starting material. Virus was
quantiﬁed by plaque titration on MRC5 cells.
To isolate viral DNA from lysate stocks, 0.1 ml samples were
diluted to 0.5 ml with 20 mM Tris, pH 8.0, 10 mM EDTA, 1 MNaCl, and
treated with 50 mg/ml proteinase K and 0.2% SDS for 3 h at 37 °C.
Following extraction with phenol and chloroform, the samples were
treated with 40 μg/ml RNAse A for 1 h, re-extracted, and nucleic acid
was collected by ethanol precipitation. The nucleic acid was
suspended in 20 μl of 10 mM Tris, ph 8.0, 0.1 mM EDTA and 2 μl was
used as template for PCR reactions.
BAC mutagenesis
The UL84 gene in BAC clones was replaced by an E. coli
galactokinase gene (galK) expression cassette using PCR ampliﬁed
DNA fragment-directed recombination and selection for galactose
utilization as described (Warming et al., 2005). The galK expression
cassette was ampliﬁed using two primers. The forward primer
included 50 nucleotides 5′ of the ATG for UL84 (sense strand) and
25 nucleotides from the 5′ end of the sense strand of the galK cassette
(5′-CTGCATATTTAAAGGCTGAGCCGGCCCTCTCGCGCCCGCAGACAC-
CAAGCCCTGTTGACAATTAATCATCGGCA-3′). The reverse primer in-
cluded 50 nucleotides 5′ of the UL84 termination codon (anti-sense
strand) and 20 nucleotides from the 5′ end of the anti-sense strand of
the galK cassette (5′-CGTATCGCGCGGACGCCTAGTGTCCGTTTCCCAT-
CACCAGGGTCCTCTGTTCAGCACTGTCCTGCTCCTT-3′). The primers
were used to amplify the galK cassette from the plasmid pgalK
(Warming et al., 2005) and the PCR product was puriﬁed using an
IllustraTM GFXTM PCR DNA puriﬁcation column (GE Healthcare). E. coli
SW105 containing BACDNAweremade competent by growth in YENB
(7.5 g/l yeast extract; 8.0 g/l nutrient broth) containing 12.5 mg/ml
chloramphenicol to an OD600 of 0.55 to 0.6 at 32 °C and then 10 ml of
culturewas transferred to 42 °C for 15 min. The cells were chilled in an
ice water bath, collected by centrifugation and washed twice with ice
cold water. After the last wash, the cell pellet was suspended in
residual liquid (0.1 – 0.15 ml total volume), 0.05 ml was mixed with
about 50 ng of ampliﬁed DNA product, and the mixture was
transferred to a 2-mm gap electroporation cell (SpectroCell). Electro-
poration was at 2.5 kV/25 μFD, 200 Ohms, in the Bio-Rad Gene-Pulser.
The cells were suspended in 1 ml of YENB and incubated at 32 °C for
1 h. Cells were collected, washed three times with M9 medium (6 g/
l Na2HPO4, 3 g/l KH2PO4, 1 g/l NH4CL, 0.5 g/l NaCl), suspended in 1 ml
of M9, and plated on minimal medium with 0.2% galactose and12.5 μg/ml chloramphenicol. Colonies were picked and screened for
red colony production on MacConkey agar with galactose. The BAC
DNA in candidate cloneswas isolated as described above and analyzed
by restriction enzyme digestion and PCR for the appropriate structure.
To assay for the UL84 gene, DNA sampleswere ampliﬁedwith a primer
in the UL84 gene (5′-TCAACAGCGGCGTGATGATAC-3′) and one in the
adjacent UL85 gene (5′-GCCTACACCAGTTCGTAGATCAC-3′). To assay
for GalK replacement of UL84, DNA samples were ampliﬁed with a
primer in the GalK sequence, 5′-CGCACAAATCGCGCTTAACGGTCAG-
GAAGC-3′, and a primer in the nearby UL82 gene (5′-GGGAAAAA-
GATGGTGTCGTGAGTCTG-3′).
Protein analysis
Mouse monoclonal antibodies directed against pUL84 (1G3 and
9G3), pIE1 (1B12), and pIE2 (3A9) were kindly provided by T. Shenk.
Mouse monoclonal antibody against tubulin (clone DM1-a) was
obtained from Sigma-Aldrich.
Immunoﬂuorescence was performed on MRC5 cells growing and
infected on cover slips. Cells were ﬁxed with freshly prepared 4%
paraformaldehyde in phosphate buffered saline (PBS) and then with
methanol. Cells were stained with primary antibody diluted 1:50 to
1:100 in 3% bovine serum albumin in phosphate-buffered saline (BSA-
PBS) for a period of 1 h to overnight at room temperature in a
humidiﬁed chamber. Secondary antibody, sheep anti-mouse IgG
conjugated to CY3 (Sigma-Aldrich C2181), was diluted 1:300 in
BSA-PBS and added for 30 min at room temperature. Cover slips were
mounted on slides with Vectashield H-1000 (Vector Laboratories).
Immunoﬂuorescencewas visualized in a Nikon Eclipse TE300 inverted
microscope equipped for ﬂuorescence microscopy with a mercury
lamp and ﬁlter 96157 (G-2E/C), and images were captured with a
“Cool Snap” digital camera (RS photometrics) processed with
MetaVue imaging software (Molecular Devices).
Expression of green ﬂuorescent protein in live cells infected with
gfp-expressing viruses was detected using the same microscopic
apparatus equipped with the 96106 (B-2A) ﬁlter.
Immunoblotting was performed as described previously (Sama-
niego et al., 1994) except that the Trans-Blot SD™ Semi-Dry
Transfer Cell apparatus (Bio-Rad) was used for protein transfer.
Primary antibodies were used at a concentration of 1:100 to 1:200
(HCMV antibodies) or 1:5000 (anti-tubulin). Secondary antibody
(goat anti-mouse, horse radish peroxidase-conjugated, Jackson
Immunologicals No.115-035-003) was used at 1:20,000. Color was
developed using the SuperSignalR West Pico detection system
(Thermo Scientiﬁc).
DNA analysis
DNA blot hybridization was performed as described previously
(Spector, 1983) except probes were labeled using Amersham™
Ready-To-Go™ DNA labeling beads (GE Healthcare). A 1285 base
pair probe for UL84 was ampliﬁed from viral BAC clones with the
primers 5′-GAGTGTAGCGTGGATTTGACTTGG-3′ and 5′-AAACACGA-
CATCCGTCAGCCTC-3′. A 1240 base pair probe for GalK was ampliﬁed
from the Galk cassette in plasmid pgalK (Warming et al., 2005) with
the primers 5′-GGGATCCTGTTGACAATTAATCATCGGCA-3′ and 5′-
GGATATCAGCACTGTCCTGCTCCTT-3′.
Viral DNA accumulation was assayed after infections performed in
6-well tissue culture plates. Cells were infected at a multiplicity of
about 0.5 for 1 h. The infecting ﬂuid was removed, the cells were
washed, and fresh medium was added. GFP ﬂuorescence was
monitored throughout the time course to conﬁrm that the same
fraction of cells was infectedwith each virus. At 8 h after infection, and
at four 1-day intervals beginning at 24 hpi, DNA was extracted from
duplicate wells using the QiaAmp DNA Mini Kit (Qiagen Corp)
according to the protocol provided by the supplier. Triplicate samples
176 Rapid Communicationwere analyzed by qPCR using the Opticon 2 detection system (Bio-Rad
Corp). HCMV UL99 DNA sequences were ampliﬁed with primers 5′-
GTGTCCCATTCCCGACTCG-3′ and 5′-TTCACAACGTCCACCCACC-3′.
Values obtained were normalized for cell number using GAPDH
genomic DNA sequences ampliﬁed with primers 5′-GATATTGTTGC-
CATCAATGAC-3′ and 5′-TTGATTTTGGAGGGTCTCG-3′.
Growth curves
Growth curves were performed in 12-well tissue culture plates.
Cells were infected at a multiplicity of about 0.01 for 1 h. The infecting
ﬂuid was removed, the cells were washed, and fresh medium was
added. On the same day, and at 4-day intervals, cells and medium
were removed from duplicate wells and placed in separate micro-
centrifuge tubes for storage at −80 °C. Prior to plaque titration,
samples were thawed, soniﬁed, and debris was removed by
centrifugation.
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